|
Intarcia
Nov 06, 2009 - Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting more>>
GeminX Biotechnologies
May 30, 2009 - Gemin X Announces Positive Results in Small Cell Lung Cancer from Phase 1b Trial of Obatoclax at Annual Meeting of the American Society of Clinical Oncology more>>
Calypso Medical Technologies
02.16.2010 - Urology Study Shows Reduced Side Effects from Radiation for Prostate Cancer with Calypso Medical’s Tumor Tracking Technology
more>>
U-Systems
November 2009 - U-SYSTEMS INTRODUCES SIGNIFICANT UPGRADE TO SUPPORT GROUND-BREAKING ULTRASOUND BREAST CANCER SCREENING STUDY more>>
NuGEN Technologies
December 2, 2009 - NuGEN enters the Next Generation Sequencing arena with the Ovation® RNA-Seq System
The first sample preparation solution for RNA-Seq enabling a complete understanding of the transcriptome from picograms of total RNA more>>
Optimer Pharmaceuticals
(3.1.2010) SAN DIEGO, CA - Optimer Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference
more>>
(2.24.2010) SAN DIEGO, CA - Optimer Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
more>>
Kadmus Pharmaceuticals
geneticXchange
Perlegen Sciences
Perlegen Introduces BREVAGen™ Breast Cancer Risk Stratification Test - September 23, 2009 more>>
NOTE: Perlegen Has Renamed Its Breast Cancer Risk Evaluation Genetic Test—
BREVAGen™ (Formerly MammaPLUS™) - August 25, 2009 more>>
Zyomyx
Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries
Zyomyx's innovative approach enters final phase to become the world's first low-cost, instrument-free test for measuring CD4 T-cell count in HIV/AIDS patients
Hayward, Calif. – November 17, 2009 – Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London’s CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients...
more>>
|
